Evidence map›Paper›PMID 33340032›Full record

ArticleNature metabolism2021

Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.

Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi, Victoria C Yan, Yasaman Barekatain, Sunada Khadka, Jeffrey J Ackroyd, Dimitra K Georgiou, Cong-Dat Pham, Kenisha Arthur and 21 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 2 institutions in 1 country.

Yu-Hsi LinDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-5763-1530
Nikunj SataniDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-3908-3731
Naima HammoudiDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Victoria C YanDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yasaman BarekatainDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sunada KhadkaDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jeffrey J AckroydDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dimitra K GeorgiouDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cong-Dat PhamDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-0747-4343
Kenisha ArthurDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
David MaxwellInstitutional Analytics & Informatics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-5926-8501
Zhenghong PengCardtronics, Inc, Houston, TX, USA.
Paul G LeonardCore for Biomolecular Structure and Function, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Barbara CzakoInstitute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Federica PisaneschiDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-1989-4417
Pijus MandalInstitute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yuting SunInstitute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-0975-7902
Rafal ZielinskiDepartment of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Susana Castro PandoDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Xiaobo WangDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-0397-919X
Theresa TranDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Quanyu XuPharmaceutical Science Facility, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Qi WuPharmaceutical Science Facility, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yongying JiangPharmaceutical Science Facility, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zhijun KangInstitute for Applied Cancer Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
John M AsaraDepartment of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Waldemar PriebeDepartment of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
William BornmannDirector of Drug Discovery and Development, Advanced Organic Synthesis LLC, Houston, Texas, USA.
Joseph R MarszalekCenter for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ronald A DePinhoDepartment of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Florian L MullerDepartment of Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, USA. aettius@aol.com.
The University of Texas MD Anderson Cancer Center · USBeth Israel Deaconess Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33340032
OpenAlexW3115547480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.